Template:Cefpirome: Difference between revisions

Jump to navigation Jump to search
mNo edit summary
mNo edit summary
Line 5: Line 5:
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefpirome compositiion|Composition]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefpirome compositiion|Composition]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefpirome properties|Properties]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefpirome properties|Properties]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefpirome clinical pharmacology|Clinical Pharmacology]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefpirome indications|Indications]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefpirome microbiology|Microbiology]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefpirome indications and usage|Indications and Usage]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefpirome contraindications|Contraindications]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefpirome contraindications|Contraindications]]

Revision as of 15:13, 2 January 2014